Financials

  • Market Capitalization 56.89 M
  • Employee 162
  • Founded 2015
  • CEO N/A
  • Website www.gossamerbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00MVWLLM2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.05
Rapporto prezzo/fatturato
14.62

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4115
RNXT
RenovoRx, Inc. - Common Stock
1.25 USD-2.34%-14.97%-28.57%+9.65%56.41 M USD
4121
OABIW
OmniAb, Inc. - Warrant
0.3875 USD0.00%0.00%-0.64%+130.65%56.34 M USD
4128
ALDX
Aldeyra Therapeutics, Inc. - Common Stock
0.91 USD-1.09%-1.09%-32.59%-83.15%54.90 M USD
4131
KLRS
Kalaris Therapeutics, Inc. - Common Stock
2.26 USD-4.24%-20.14%-33.72%-77.91%53.80 M USD

Notizie